✦ LIBER ✦

Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen–positive blood donations

✍ Scribed by Françoise Bouchardeau; Annie Girault; Annie Razer; Annabelle Servant-Delmas; Mélanie Mercier; Syria Laperche

Book ID: 109143417
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 91 KB
Volume: 46
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2006.01031.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B virus DNA–positive, hepatiti

Hepatitis B virus DNA–positive, hepatitis B surface antigen–negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience

✍ Sheila F. O'Brien; Margaret A. Fearon; Qi-Long Yi; Wenli Fan; Vito Scalia; Irene 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 114 KB

The absence of hepatitis B virus DNA in

The absence of hepatitis B virus DNA in hepatitis B e antigen positive sera from chronic hepatitis B surface antigen carriers in China

✍ Janet S. Scott; Pei-En Pan; Raymond A. Pace; Theo P. Sloots; Prof. W. Graham Coo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

## Abstract Sera from 20 Chinese patients with chronic hepatitis B were examined for hepatitis B e antigen and hepatitis B virus (HBV) DNA. There was considerable discordance with HBV DNA not being detectable in 10 out of 13 (77%) patients who were hepatitis B e antigen positive. Further testing fo

Lack of correlation between hepatitis B

Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors

✍ Jean-Pierre Allain; Francis Sarkodie; Daniel Candotti; Ohene Opare-Sem 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Multicenter performance evaluation of a

Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations

✍ Marco H.G.M. Koppelman; Azzedine Assal; Michael Chudy; Pilar Torres; R. Garcia D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Multicenter performance evaluation of a

Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 32 KB

Efficacy of lamivudine in patients with

Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60